These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33077304)

  • 1. Re: Roman Sosnowski, Hubert Kamecki, Steven Joniau, Jochen Walz, Zachary Klaassen, Joan Palou. Introduction of Telemedicine During the COVID-19 Pandemic: A Challenge for Now, an Opportunity for the Future. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.007.
    Allen-Tejerina AM; Rallis KS; Szabados B
    Eur Urol; 2021 Jan; 79(1):e26-e27. PubMed ID: 33077304
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Jan-Niclas Mumm, Andreas Osterman, Michael Ruzicka, et al. Urinary Frequency as a Possible Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.05.013: Severe Involvement of the Urinary Tract During COVID-19 Infection.
    Luciani LG; Gallo F; Malossini G
    Eur Urol; 2020 Sep; 78(3):e129-e130. PubMed ID: 32591102
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024.
    Kazybay B; Xie Y
    Eur Urol; 2021 Nov; 80(5):e115-e116. PubMed ID: 34511304
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Bexultan Kazybay and Yingqiu Xie's Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024.
    Coelingh Bennink HJT; Foidart JM; Debruyne FMJ
    Eur Urol; 2021 Nov; 80(5):e117-e118. PubMed ID: 34509303
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002.
    Vale C; Fisher D; Tierney J; White I; Sydes M; Carpenter J
    Eur Urol; 2018 Mar; 73(3):e49-e50. PubMed ID: 29233663
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057.
    van der Poel HG; Buckle T; Valdes Olmos R
    Eur Urol; 2013 Feb; 63(2):e20. PubMed ID: 23153744
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Peng He, Xiaohui Wang, and Hao Li's Letter to the Editor re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025.
    Xiao Y; Qian K; Luo Y; Chen S; Lu M; Wang G; Ju L; Wang X
    Eur Urol; 2020 Nov; 78(5):e203-e204. PubMed ID: 32405138
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041.
    Davies B; Kowalczyk K
    Eur Urol; 2022 Jul; 82(1):e11. PubMed ID: 35428507
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Benjamin Davies, Keith Kowalczyk RE: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041.
    Klaassen Z; Catto JWF; Vickers AJ; Cooperberg MR; Kutikov A
    Eur Urol; 2022 Jul; 82(1):e12. PubMed ID: 35428508
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Maria J. Ribal, Philip Cornford, Alberto Briganti, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.056: Metastatic Prostate Cancer and COVID-19: Do Current Data Allow Modification of Established Treatment Recommendations?
    Thomas C; Grüllich C; Erb HHH
    Eur Urol Focus; 2020 Sep; 6(5):1135-1136. PubMed ID: 32534970
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025.
    He P; Wang X; Li H
    Eur Urol; 2020 Jul; 78(1):e25-e26. PubMed ID: 32345521
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al. Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.018: The Next Surgical Frontier in Kidney Cancer: Nephrectomy After Immune Checkpoint Inhibition.
    Singla N; Margulis V
    Eur Urol; 2020 Aug; 78(2):e79-e80. PubMed ID: 32362497
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Claire Vale, David Fisher, Jayne Tierney, Ian White, Matthew Sydes, and James Carpenter's Letter to the Editor re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002.
    Wallis CJD; Klaassen Z
    Eur Urol; 2018 Mar; 73(3):e51. PubMed ID: 29224912
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Henk G. van der Poel, Tessa Buckle and Renato Valdes Olmos' letter to the editor re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057.
    Joniau S; Van den Bergh L
    Eur Urol; 2013 Feb; 63(2):e21-2. PubMed ID: 23149147
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction of Telemedicine During the COVID-19 Pandemic: A Challenge for Now, an Opportunity for the Future.
    Sosnowski R; Kamecki H; Joniau S; Walz J; Klaassen Z; Palou J
    Eur Urol; 2020 Dec; 78(6):820-821. PubMed ID: 32703638
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Nirmish Singla and Vitaly Margulis's Letter to the Editor re: Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al. Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.018. The Next Surgical Frontier in Kidney Cancer: Nephrectomy After Immune Checkpoint Inhibition: Nephrectomy After Immunotherapy: The Duration of Treatment Exposure is Probably Decisive.
    Pignot G; Thiery-Vuillemin A; Walz J; Bigot P; Bensalah K; Gravis G; Barthélémy P
    Eur Urol; 2020 Aug; 78(2):e81-e82. PubMed ID: 32389444
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Marko Babjuk. Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.01.022.
    Lu C; Guan X
    Eur Urol; 2020 Aug; 78(2):e71-e72. PubMed ID: 32389445
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Hojjat Ahmadzadehfar, Markus Essler. Prostate-specific Membrane Antigen Imaging: A Game Changer in Prostate Cancer Diagnosis and Therapy Planning. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.028.
    Wang B; Deng H; Cao L
    Eur Urol; 2019 Nov; 76(5):e125. PubMed ID: 31109815
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Can Lu and Xiao Guan's Letter to the Editor re: Marko Babjuk. Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.01.022.
    Babjuk M
    Eur Urol; 2020 Aug; 78(2):e73-e74. PubMed ID: 32389446
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathon I. Epstein, et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.017.
    Froehner M; Koch R; Thomas C
    Eur Urol; 2020 Aug; 78(2):e91. PubMed ID: 32381458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.